Epigenetic Trends in Technology and Research
Enal Razvi, PhD is biotechnology analyst and Managing Director US at Select Biosciences
He spoke to Pharma IQ about his recent report on Epigenetic research classes and Assay Trends with Genetic Engineering & Biotechnology News (GEN)
TO READ THE FULL STORY
Please note: That all fields marked with an asterisk (*) are required.